Explore Now
Nifty futures on the Singapore Exchange traded 209 points, or 1.41 per cent, higher at 15,073.50 in signs that Dalal Street was headed for a gap-up start on Thursday. Here are a few stocks whihc may buzz the most in today s trade:
Dr Reddy s Labs: The subject expert committee under India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine, citing lack of data.
Nureca: The company, which is into the business of home healthcare and wellness products, will make market debut today. The Rs 100 crore IPO, which was sold from February 15 to Ferbuary 17, was subscribed 39.93 times. The category meant for qualified institutional buyers (QIBs) was subscribed 3.10 times, non institutional investors 31.59 times and retail individual investors (RIIs) 166.65 times.
Axis entities-Max Life Insurance deal gets IRDAI s nod telegraphindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraphindia.com Daily Mail and Mail on Sunday newspapers.
Max Financial hits 52-week high on regulatory approval for deal with Axis Bank
Shares of Max Financial Services hit a 52-week high of Rs938.65 apiece on Thursday on the National Stock Exchange (Photo: iStock)Premium
1 min read
Share Via
Read Full Story
MUMBAI: Shares of Max Financial Services hit a 52-week high of Rs938.65 apiece on Thursday on the National Stock Exchange, rising 6.3% from previous close, following the insurance regulator s approval for its deal with Axis Bank.
As part of the deal, Axis Bank with its subsidiaries, Axis Securities Limited and Axis Capital Limited, will acquire up to 19% stake in Max Life Insurance, part of Max Financial. Of the total stake to be bought, Axis Bank proposes to acquire up to 9% and Axis Capital Limited and Axis Securities Limited together will acquire up to 3% of the share capital of Max Life in the first leg of the transaction.
Max Life outpaces pvt life insurance industry in Apr-Dec, expects over 11 pc biz growth in FY21: CEO indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Outpacing the industry s growth at 11 per cent during nine months to December 2020 amidst the pandemic, Max Life Insurance hopes to post even better numbers at the close of 2020-21 on the back of strong distribution network and digital expansion, the company s top official said. Max Life outperformed the private sector life insurance industry as well as top-three private players in the first nine months of 2020-21, wherein top-10 private players de-grew by 5 per cent. At the end of nine months of this fiscal, we have grown at about 11 per cent. And, we hope that the number will get accelerated further. We are expected to grow higher than 11 per cent (by the end of March 2021), Max Life Managing Director and CEO Prashant Tripathy told in an interview with PTI.